Photo from wikipedia
Key Points • There are no prior prospective studies of thrombopoietin receptor agonists to enhance platelet recovery after auto-HCT.• As studied, romiplostim did not shorten the duration and depth of… Click to show full abstract
Key Points • There are no prior prospective studies of thrombopoietin receptor agonists to enhance platelet recovery after auto-HCT.• As studied, romiplostim did not shorten the duration and depth of the platelet nadir, but it enhanced platelet recovery after day +15.
Keywords:
label pilot;
open label;
study romiplostim;
pilot study;
romiplostim thrombocytopenia;
thrombocytopenia autologous
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!